These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccination and herd immunity: what more do we know? Rashid H; Khandaker G; Booy R Curr Opin Infect Dis; 2012 Jun; 25(3):243-9. PubMed ID: 22561998 [TBL] [Abstract][Full Text] [Related]
3. [The concept of herd immunity applied to the evaluation of vaccination programs]. Zieliński A Przegl Epidemiol; 1999; 53(3-4):245-55. PubMed ID: 10800562 [TBL] [Abstract][Full Text] [Related]
4. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. Gomes MG; White LJ; Medley GF J Theor Biol; 2004 Jun; 228(4):539-49. PubMed ID: 15178201 [TBL] [Abstract][Full Text] [Related]
5. An unprotected public. Kahn J Am J Bioeth; 2008 Jun; 8(6):3-4. PubMed ID: 18726767 [No Abstract] [Full Text] [Related]
6. Prevalence of antibodies associated with herd immunity: a new indicator to evaluate the establishment of herd immunity and to decide immunization strategies. Plans P Med Decis Making; 2010; 30(4):438-43. PubMed ID: 20400729 [TBL] [Abstract][Full Text] [Related]
8. [Progress in assessment of vaccine on herd protection]. Jin PF; Li JX; Zhu FC Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):862-866. PubMed ID: 29936762 [TBL] [Abstract][Full Text] [Related]
9. Control of transmission with two types of infection. Ball F; Becker NG Math Biosci; 2006 Apr; 200(2):170-87. PubMed ID: 16494902 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of indirectly transmitted infectious diseases with immunological threshold. Joh RI; Wang H; Weiss H; Weitz JS Bull Math Biol; 2009 May; 71(4):845-62. PubMed ID: 19096894 [TBL] [Abstract][Full Text] [Related]
12. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules? Lang PO; Aspinall R Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666 [TBL] [Abstract][Full Text] [Related]
13. New approaches to the assessment of vaccine herd protection in clinical trials. Clemens J; Shin S; Ali M Lancet Infect Dis; 2011 Jun; 11(6):482-7. PubMed ID: 21616458 [TBL] [Abstract][Full Text] [Related]
14. Host factors affecting disease transmission. Muzyka BC Dent Clin North Am; 1996 Apr; 40(2):263-75. PubMed ID: 8641520 [TBL] [Abstract][Full Text] [Related]
15. Patient education. Guidelines for exclusion from school. Aust Fam Physician; 2003 Aug; 32(8):613-4. PubMed ID: 12973868 [No Abstract] [Full Text] [Related]
16. Modelling infectious diseases with herd immunity in a randomly mixed population. Law KB; M Peariasamy K; Mohd Ibrahim H; Abdullah NH Sci Rep; 2021 Oct; 11(1):20574. PubMed ID: 34663839 [TBL] [Abstract][Full Text] [Related]
17. HIV, infectious diseases, and competitive athletics. Feller AA; Flanigan TP Med Health R I; 2000 Feb; 83(2):56-9. PubMed ID: 10730055 [No Abstract] [Full Text] [Related]
18. Herd immunity. Ashby B; Best A Curr Biol; 2021 Feb; 31(4):R174-R177. PubMed ID: 33621500 [TBL] [Abstract][Full Text] [Related]